Abstract:Cryo-electron
microscopy (cryo-EM)-based structure determination
of small proteins is hindered by the technical challenges associated
with low signal-to-noise ratios of their particle images in intrinsically
noisy micrographs. One solution is to attach the target protein to
a large protein scaffold to increase its apparent size and, therefore,
image contrast. Here we report a novel scaffold design based on a
trimeric helical protein, E. coli ornithine transcarbamylase
(OTC), fused to human ubiquitin. As a proo… Show more
“…Its interaction is structurally well characterized with the Ub-bound structure having been solved by both X-ray crystallography and cryo-electron microscopy (CryoEM). [28,40] Our Ub T9Bpa crosslinking results show that there is one equivalent of Ub binding as suggested by SDS-PAGE gel. Photocrosslinking reaction mixtures were subjected to tryptic digestion and analysis by LC-MS/MS.…”
Ubiquitin (Ub) proteoforms control nearly every aspect of eukaryotic cell biology through their diversity. Inspired by the widely used Ub C-terminal electrophiles (UbÀ E), here we report the identification of multivalent binding of Ub with deubiquitylating enzymes (Dubs) using genetic code expansion (GCE) and crosslinking mass spectrometry. While the UbÀ Es only gather structural information with the S1 Dub sites, we demonstrate that GCE of Ub with p-benzoyl-L-phenylalanine enables identification of interaction modes beyond the S1 site with a panel of Dubs of both eukaryotic and prokaryotic origin. Collectively, this represents the next generation of Ub-based affinity probes with a unique ability to unravel Ub interaction landscapes beyond what is afforded by cysteine-based chemistries.
“…Its interaction is structurally well characterized with the Ub-bound structure having been solved by both X-ray crystallography and cryo-electron microscopy (CryoEM). [28,40] Our Ub T9Bpa crosslinking results show that there is one equivalent of Ub binding as suggested by SDS-PAGE gel. Photocrosslinking reaction mixtures were subjected to tryptic digestion and analysis by LC-MS/MS.…”
Ubiquitin (Ub) proteoforms control nearly every aspect of eukaryotic cell biology through their diversity. Inspired by the widely used Ub C-terminal electrophiles (UbÀ E), here we report the identification of multivalent binding of Ub with deubiquitylating enzymes (Dubs) using genetic code expansion (GCE) and crosslinking mass spectrometry. While the UbÀ Es only gather structural information with the S1 Dub sites, we demonstrate that GCE of Ub with p-benzoyl-L-phenylalanine enables identification of interaction modes beyond the S1 site with a panel of Dubs of both eukaryotic and prokaryotic origin. Collectively, this represents the next generation of Ub-based affinity probes with a unique ability to unravel Ub interaction landscapes beyond what is afforded by cysteine-based chemistries.
“…Soluble expression and purification will be crucial for structural characterization via CD, NMR, and Cryo-EM. Due to their small size and high disorder content, only NMR 25 and potentially Cryo-EM 64 will be capable of solving the structure of de novo proteins experimentally. Even in light of the recent dawn of computational structure prediction, 65,66 experimental structural and functional determination remains necessary, especially for de novo proteins.…”
Over the past decade, evidence has accumulated that new protein‐coding genes can emerge de novo from previously non‐coding DNA. Most studies have focused on large scale computational predictions of de novo protein‐coding genes across a wide range of organisms. In contrast, experimental data concerning the folding and function of de novo proteins are scarce. This might be due to difficulties in handling de novo proteins in vitro, as most are short and predicted to be disordered. Here, we propose a guideline for the effective expression of eukaryotic de novo proteins in Escherichia coli. We used 11 sequences from Drosophila melanogaster and 10 from Homo sapiens, that are predicted de novo proteins from former studies, for heterologous expression. The candidate de novo proteins have varying secondary structure and disorder content. Using multiple combinations of purification tags, E. coli expression strains, and chaperone systems, we were able to increase the number of solubly expressed putative de novo proteins from 30% to 62%. Our findings indicate that the best combination for expressing putative de novo proteins in E. coli is a GST‐tag with T7 Express cells and co‐expressed chaperones. We found that, overall, proteins with higher predicted disorder were easier to express.
Statement
Today, we know that proteins do not only evolve by duplication and divergence of existing proteins but also arise from previously non‐coding DNA. These proteins are called de novo proteins. Their properties are still poorly understood and their experimental analysis faces major obstacles. Here, we aim to present a starting point for soluble expression of de novo proteins with the help of chaperones and thereby enable further characterization.
“…Conclusions. While cryoEM structures of molecules smaller that 100 kDa in size are available [25][26][27][28]31 they have been often the results of a one-off process that tested the current technology and software, or obtained by extensive manipulation of the sample itself 26,[47][48][49] but did not address the need for reproducibility in structure determination, as well as the necessity of identifying ligands bound, two essential requirement for the use of cryoEM derived information in drug discovery and development. In this paper we have shown that routine structural determination of molecules less than 70 kDa in size is possible, and that visualization of bound ligands is achievable.…”
Human serum albumin (HSA) is the most prevalent plasma protein in the human body, accounting for 60% of the total plasma protein. HSA plays a major pharmacokinetic function, serving as a facilitator in the distribution of endobiotics and xenobiotics within the organism. In this paper we report the cryoEM structures of HSA in the apo form and in complex with two ligands (salicylic acid and teniposide) at a resolution of 3.5, 3.7 and 3.4 Å, respectively. We expand upon previously published work and further demonstrate that sub-4 Å maps of ∼60 kDa proteins can be routinely obtained using a 200 kV microscope, employing standard workflows. Most importantly, these maps allowed for the identification of small molecule ligands, emphasizing the practical applicability of this methodology and providing a starting point for subsequent computational modeling and in silico optimization.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.